7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen PlanusCutaneous Lichen Planus, Lichenoid Eruptions, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, lichen planus, skin disorderRecruitingPhase 22026-09-25NCT07775924
Safety and Efficacy of HB-1 for Post-Traumatic Stress DisorderStress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorderRecruitingPhase 22026-09-24NCT07499440
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental VitiligoSkin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligoRecruitingPhase 22026-09-09NCT07431177
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneAcneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorderRecruitingPhase 1 / Phase 22026-08-21NCT06316297
Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)nodular basal cell carcinomaRecruitingPhase 12026-06-29NCT07670858
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverDNA Virus Infections, Herpesviridae infectious disease, Infections, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, herpes zoster, viral infectious diseaseActive, not recruitingPhase 1 / Phase 22026-05-29NCT06569823
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorderRecruitingPhase 22025-08-01NCT06855745